Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026

Go back to Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026
(NYSE: LCTX) Delayed: 1.07 -0.02 (1.83%)
Previous Close $1.09    52 Week High
Open $1.11    52 Week Low
Day High $1.12    P/E N/A 
Day Low $1.05    EPS
Volume 385,189       

(NYSE: LCTX) Delayed: 1.07 -0.02 (1.83%)
Previous Close $1.09    52 Week High
Open $1.11    52 Week Low
Day High $1.12    P/E N/A 
Day Low $1.05    EPS
Volume 385,189